Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04476329 |
Title | Optimization for Regorafenib in HCC (ReDos HCC) |
Acronym | ReDos HCC |
Recruitment | Terminated |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | SC Liver Research Consortium, LLC |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Banner MD Anderson Cancer Center | Gilbert | Arizona | 85234 | United States | Details | |
VA Long Beach Health System | Long Beach | California | 90822 | United States | Details | |
Tulane University | New Orleans | Louisiana | 70112 | United States | Details | |
Henry Ford Health Systems | Detroit | Michigan | 48202 | United States | Details | |
Cancer and Hematology Centers of Western Michigan | Grand Rapids | Michigan | 49503 | United States | Details | |
Saint Louis University | Saint Louis | Missouri | 63104 | United States | Details | |
Comprehensive Cancer Centers of Nevada | Henderson | Nevada | 89014 | United States | Details | |
University of Cincinnati Medical Center | Cincinnati | Ohio | 45219 | United States | Details | |
Albert Einstein Medical Center | Philadelphia | Pennsylvania | 19141 | United States | Details |